12-52469213-T-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_173086.5(KRT6C):āc.1544A>Cā(p.Tyr515Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,800 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_173086.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT6C | NM_173086.5 | c.1544A>C | p.Tyr515Ser | missense_variant | 9/9 | ENST00000252250.7 | NP_775109.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT6C | ENST00000252250.7 | c.1544A>C | p.Tyr515Ser | missense_variant | 9/9 | 1 | NM_173086.5 | ENSP00000252250 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251182Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135756
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461684Hom.: 1 Cov.: 36 AF XY: 0.0000536 AC XY: 39AN XY: 727148
GnomAD4 genome AF: 0.000105 AC: 16AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74348
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2022 | The c.1544A>C (p.Y515S) alteration is located in exon 9 (coding exon 9) of the KRT6C gene. This alteration results from a A to C substitution at nucleotide position 1544, causing the tyrosine (Y) at amino acid position 515 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 16, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at